Most common adverse reactions include: anorexia, epigastric discomfort, nausea, vomiting, diarrhea, depression, dizziness, vertigo, rash, hypercholesterolemia, hypertriglyceridemia, hypothyroidism, and decreased blood free testosterone in males.
from FDA,2024.01
Regarding the clinical application and medication specifications of mitotane, th···【more】
Release date:2025-05-08Recommended:173
Understanding drug properties and treatment costs is an important reference for ···【more】
Release date:2025-05-07Recommended:196
The potential impact of medication is a core concern that patients must focus on···【more】
Release date:2025-05-07Recommended:191
Mitotane is a drug dedicated to the treatment of adrenocortical carcinoma (inope···【more】
Release date:2024-08-20Recommended:232
Mitotaneis a drug used to treat inoperable adrenal cortical carcinoma, adrenal h···【more】
Release date:2024-08-20Recommended:201
Mitotaneis a highly potent antineoplastic drug specifically designed to treat in···【more】
Release date:2024-08-19Recommended:251